About Anteris Technologies
Anteris Technologies is a company based in Brisbane (Australia) founded in 2011. The company has 136 employees as of December 31, 2024. Anteris Technologies offers products and services including DurAVR® THV. Anteris Technologies operates in a competitive market with competitors including Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Brisbane, Australia
- Employees 136 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Anteris Technologies Global Corp.
-
Annual Revenue
$2.7 M (USD)-1.16as on Dec 31, 2024
-
Net Profit
-$76.29 M (USD)-65.77as on Dec 31, 2024
-
EBITDA
-$76.86 M (USD)-66.32as on Dec 31, 2024
-
Latest Funding Round
$11.5 M (USD), Post-IPO
Oct 23, 2025
-
Investors
HHS
& 3 more
-
Employee Count
136
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Anteris Technologies
Anteris Technologies is a publicly listed company on the NASDAQ with ticker symbol AVR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Anteris Technologies
Anteris Technologies offers a comprehensive portfolio of products and services, including DurAVR® THV.
Transcatheter heart valve designed to mimic natural aortic function.
People of Anteris Technologies
Unlock access to complete
Funding Insights of Anteris Technologies
Investors in Anteris Technologies
Anteris Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Mercer and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Locked | Locked | Locked | |
|
Consulting and investment services are provided to organizations across sectors.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Anteris Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Anteris Technologies
Investment portfolio details for Anteris Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Anteris Technologies
Detailed financials for Anteris Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anteris Technologies Comparisons
Peer comparison for Anteris Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Anteris Technologies
Anteris Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Venus MedTech, Cardiac Dimensions, Pi-Cardia and Peijia Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
|
| Locked | Locked | Locked |
Smart medical devices for heart valve diseases are developed.
|
Detailed competitors of Anteris Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anteris Technologies
Complete news archive for Anteris Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anteris Technologies
Anteris Technologies was founded in 2011.
Anteris Technologies is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Wayne Paterson is the current CEO of Anteris Technologies.
As of Dec 31, 2024, the latest employee count at Anteris Technologies is 136.
Annual revenue of Anteris Technologies is $2.7M as on Dec 31, 2024.
Anteris Technologies was founded in 2011 in Brisbane, Australia, focusing on medical device innovations in the cardiovascular sector. Patented ADAPT technology is utilized to create the 3D single-piece DurAVR aortic heart valve. Additional products include the DurAVR leaflet repair system, transcatheter heart valve, and surgical heart valve, supporting advancements in heart valve treatments through research and development operations.
Anteris Technologies's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Anteris Technologies offers DurAVR® THV.
Yes, Anteris Technologies is publicly traded on NASDAQ under the ticker symbol AVR.
Anteris Technologies has 4 investors. Key investors include HHS, Mercer, Perceptive Advisors, and Star Bright Holding.
The ticker symbol of Anteris Technologies is AVR on NASDAQ.